desloratadine - trima syrup 0.5 mgml
trima israel pharmaceutical products maabarot ltd - desloratadine - syrup - desloratadine 0.5 mg/ml - desloratadine - for the relief of symptoms associated with allergic rhinitis and/or chronic idiopathic urticaria in adults and children 1 year of age and above.
tinden gel
trima israel pharmaceutical products maabarot ltd - dimetindene maleate - gel - dimetindene maleate 0.1 %w/w - dimetindene - urticaria, pruritis, dermatoses, burns, insect bites, allergic dermatitis and eczema.
voriconazole-trima 200mg
trima israel pharmaceutical products maabarot ltd - voriconazole - tablets - voriconazole 200 mg - voriconazole - treatment of: invasive aspergillosis, candidemia in non-neutropenic patients, fluconazole-resistant serious invasive candida infections (including c. krusei), serious fungal infections caused by scedosporium spp. and fusarium spp. voriconazole should be administered primarily to immunocompromised patients with progressive, possibly life-threatening infections. prophylaxis of invasive fungal infections in high risk allogeneic hematopoietic stem cell transplant (hsct) recipients.
kisqali 200 mg
novartis israel ltd - ribociclib as succinate - film coated tablets - ribociclib as succinate 200 mg - ribociclib - kisqali is indicated in combination with:* a non-steroid aromatase inhibitor for the treatment of pre/perimenopausal or postmenopausal women, with hormone receptor (hr)-positive, human epidermal growth factor receptor 2 (her2)-negative locally advanced or metastatic breast cancer, as initial endocrine-based therapy.or* fulvestrant for the treatment of men and postmenopausal women with hr-positive, her2-negative advanced or metastatic breast cancer, as initial endocrine based therapy or following disease progression on endocrine therapy.
clobetasol propionate trima scalp solution
trima israel pharmaceutical products maabarot ltd - clobetasol propionate - solution - external - clobetasol propionate 0.05 %w/w - clobetasol - for the topical treatment of inflammatory conditions of the scalp responsive only to corticosteroids.
oestrogel
cts ltd - estradiol - gel - estradiol 0.06 %w/w - estradiol - estradiol - hormonal replacement therapy for the treatment of symptoms associated with estrogen deficiency in menopausal women. prevention of postmenopausal osteoporosis in women with an increased risk for osteoporotic fractures and presenting intolerace or a contraindication to others treatments indicated in the prevention of osteoporosis.
exemestane teva 25 mg
abic marketing ltd, israel - exemestane - film coated tablets - exemestane 25 mg - exemestane - exemestane - exemestane teva® is indicated for the treatment of advanced breast cancer (abc) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. exemestane teva® is also indicated for the treatment of postmenopausal women with abc whose disease has progressed following multiple hormonal therapies.exemestane teva® is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breast cancer following 2-3 years of initial adjuvant tamoxifen therapy
duodopa
abbvie biopharmaceuticals ltd, israel - carbidopa as monohydrate; levodopa - gel - levodopa 20 mg/ml; carbidopa as monohydrate 5 mg/ml - levodopa - levodopa - treatment of advanced levodopa-responsive parkinson's disease with severe motor fluctuations and hyper-/dyskinesia when available combinations of parkinson medicinal products have not given satisfactory results.
allegro nasal spray
trima israel pharmaceutical products maabarot ltd - fluticasone propionate - suspension - fluticasone propionate 0.05 %w/w - fluticasone - fluticasone - self medication:prophylaxis and treatment of seasonal allergic rhinitis including hay fever in adults.by physicians order:prophylaxis and treatment of seasonal allergic rhinitis including hay fever in children of the age of4 years and above and perennial rhinitis in adults and children of the age of 4 years and above.
exemasin - vit
vitamed pharmaceutical industries ltd - exemestane - film coated tablets - exemestane 25 mg - exemestane - exemasin-vit is indicated for the treatment of advanced breast cancer (abc) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone.exemasin-vit is also indicated for the treatment of postmenopausal women with abc whose disease has progressed following multiple hormonal therapies. exemasin-vit is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy.